IO Biotech Inc. (IOBT)
NASDAQ: IOBT
· Real-Time Price · USD
2.10
-0.06 (-2.78%)
At close: Aug 18, 2025, 3:59 PM
2.10
0.00%
After-hours: Aug 18, 2025, 07:59 PM EDT
IO Biotech Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -22.42M | -31.33M | -24.02M | -20.69M | -19.46M | -26.18M | -21.68M | -21.18M | -17.04M | -20.07M | -15.69M | -18.5M | -17.2M | -21.31M | -1.09M | -41.73M | -3.75M |
Depreciation & Amortization | 227K | 219K | 205K | 214K | 211K | 201K | 194K | 187K | 174K | 190K | 119K | 11K | 220K | 2.00 | -1K | 1K | n/a |
Stock-Based Compensation | 1.57M | 1.63M | 1.68M | 1.64M | 1.57K | 1.56K | 2.99K | 1.62K | 1.89K | 1.66K | 2.4M | 1.36M | 1.62M | 1.3M | 483K | 5K | 4K |
Other Working Capital | n/a | 5.78M | 2.71M | -597K | -7.68M | 4.8M | -17K | 911K | -256K | 4.29M | 2.1K | 1.38M | -3.66M | -687K | -5.35M | 2.54M | -689K |
Other Non-Cash Items | n/a | 4.67M | -1.63M | 1.27M | 2.49M | 4.32M | 21.68M | 21.18M | -258K | -522K | -2.29K | 285K | 20K | -305K | -2.63M | 29.29M | -137K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -4.73M | -21.34M | -21.19M | n/a | 87K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 5.19M | 2.95M | 580K | -7.71M | 2.03M | 2.16M | 1.11M | 550K | 6.13M | -267K | 3.83M | -5.5M | 1.07M | -4.88M | 3.04M | -11K |
Operating Cash Flow | -23.07M | -19.63M | -20.81M | -16.98M | -24.93M | -22.8M | -15.99M | -18.26M | -14.69M | -12.53M | -13.35M | -13.01M | -20.84M | -19.24M | -8.11M | -9.4M | -3.89M |
Capital Expenditures | -28K | -11K | -10K | -12K | -11K | -112K | -24K | -39K | -148K | -349K | -118K | -107K | -116K | -153K | -3 | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -28K | -11K | -10K | -12K | -11K | -112K | -24K | -39K | -148K | -349K | -118K | -107K | -116K | -153K | -3K | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | -10K | 71.87M | n/a | n/a | n/a | n/a | n/a | n/a | 103.35M | n/a | n/a | -340K |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | -10K | 71.87M | -2.75M | n/a | n/a | n/a | n/a | n/a | 187.54M | n/a | n/a | 65.41M |
Net Cash Flow | -22.95M | -20.15M | -20.56M | -17.23M | -25.21M | -22.31M | 55.41M | -18.43M | -14.06M | -8.58M | -18.95M | -17.78M | -23.63M | 166.32M | -9.28M | -8.47M | 59.82M |
Free Cash Flow | -23.1M | -19.64M | -20.82M | -16.99M | -24.94M | -22.91M | -16.01M | -18.3M | -14.84M | -12.88M | -13.47M | -13.12M | -20.96M | -19.39M | -8.11M | -9.4M | -3.89M |